
Synthetic ACTH(4-10) analogue supplied for in-vitro laboratory characterisation.
Semax 5 mg is not yet released for sale. Batch release, HPLC certification and third-party testing are in progress. Leave your email and we'll notify you the moment it's available.
Semax is a synthetic heptapeptide corresponding to a modified fragment of adrenocorticotropic hormone (ACTH 4-10), extended with a proline–glycine–proline tail that improves its stability profile in laboratory handling.
Each vial supplied by NXT GEN RESEARCH is manufactured to strict laboratory standards, HPLC-characterised and independently third-party tested for identity and purity.
Semax is referenced in laboratory literature in fields including:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
Every batch of Semax supplied by NXT GEN RESEARCH is HPLC-characterised and independently third-party tested for identity and purity, giving researchers consistent, well-documented material for their laboratory workflow.
Lyophilised material: -20 °C. In solution: 2–8 °C; laboratory practice commonly references a working life of up to 28 days from first entry when stored correctly.
This product is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.

Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.

Copper tripeptide-1 for in-vitro biochemical characterisation.

Mitochondrial-derived peptide supplied for in-vitro laboratory research.

I am over 18 years of age. I am a professional or student researcher.
Research grade compounds · Not for human or animal consumption